Found: 10
Select item for more details and to access through your institution.
Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3832, doi. 10.3390/ijms25073832
- By:
- Publication type:
- Article
Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8849, doi. 10.3390/ijms22168849
- By:
- Publication type:
- Article
The association of testosterone with sarcopenia and frailty in chronic liver disease.
- Published in:
- European Journal of Clinical Investigation, 2024, v. 54, n. 2, p. 1, doi. 10.1111/eci.14108
- By:
- Publication type:
- Article
Circulating cell‐free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 3, p. 464, doi. 10.1111/jvh.13446
- By:
- Publication type:
- Article
Noninvasive diagnosis of hepatic steatosis in patients with severe obesity: a clinically challenging issue.
- Published in:
- Polish Archives of Internal Medicine, 2023, v. 133, n. 1, p. 1, doi. 10.20452/pamw.16415
- By:
- Publication type:
- Article
Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation.
- Published in:
- Pathogens, 2023, v. 12, n. 3, p. 394, doi. 10.3390/pathogens12030394
- By:
- Publication type:
- Article
The impact of sodium glucose co‐transporter 2 inhibitors on non‐alcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 4, p. 893, doi. 10.1111/jgh.15202
- By:
- Publication type:
- Article
Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis.
- Published in:
- Annals of Gastroenterology, 2023, v. 36, n. 4, p. 442, doi. 10.20524/aog.2023.0800
- By:
- Publication type:
- Article
Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease.
- Published in:
- Annals of Gastroenterology, 2022, v. 35, n. 3, p. 234, doi. 10.20524/aog.2022.0705
- By:
- Publication type:
- Article
Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?
- Published in:
- Annals of Gastroenterology, 2021, v. 34, n. 4, p. 476, doi. 10.20524/aog.2021.0641
- By:
- Publication type:
- Article